• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by LogicBio Therapeutics Inc. (Amendment)

    2/4/22 2:41:05 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $LOGC alert in real time by email
    SC 13G/A 1 logi21a1.htm logi21a1.htm - Generated by SEC Publisher for SEC Filing  

     

              CUSIP NO. 54142F102                    13G                               Page 1 of 13

     

     

                                                                                       UNITED STATES

                                                                  SECURITIES AND EXCHANGE COMMISSION

                                                                              Washington, D.C. 20549

     

                                                                                        SCHEDULE 13G

     

                                                           Under the Securities Exchange Act of 1934

                                                                                  (Amendment No. 1)*

     

                                                                         LogicBio Therapeutics, Inc.

                                                                                    (Name of Issuer)

     

                                                           Common Stock, par value $0.0001 per share

                                                                      (Title of Class of Securities)

     

                                                                                           54142F102

     

                                                                                      (CUSIP Number)

     

                                                                                   December 31, 2021

                                             (Date of Event Which Requires Filing of this Statement)

     

              Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

              [X] Rule 13d‑1(b)

              [ ] Rule 13d‑1(c)

              [ ] Rule 13d‑1(d)

     

              *The remainder of this cover page shall be filled out for a reporting person's initial

              filing on this form with respect to the subject class of securities, and for any

              subsequent amendment containing information which would alter the disclosures provided in

              a prior cover page.

     

              The information required in the remainder of this cover page shall not be deemed to be

              "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or

              otherwise subject to the liabilities of that section of the Act but shall be subject to

              all other provisions of the Act (however, see the Notes).

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 2 of 13

     

     

              1.    NAMES OF REPORTING PERSONS.    

     

                          Franklin Resources, Inc.

     

              2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

                          (a)

                          (b) X

     

              3.    SEC USE ONLY

     

              4.    CITIZENSHIP OR PLACE OF ORGANIZATION

     

                          Delaware

     

              NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

     

                          5.     SOLE VOTING POWER

     

                                       (See Item 4)

                          6.     SHARED VOTING POWER

     

                                       (See Item 4)

                          7.     SOLE DISPOSITIVE POWER

     

                                       (See Item 4)

                          8.     SHARED DISPOSITIVE POWER

     

                                       (See Item 4)

              9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

                           1,598,695

     

              10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

                           CERTAIN SHARES [ ]

     

              11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

                           4.9%

     

              12.   TYPE OF REPORTING PERSON

     

                           HC, CO (See Item 4)

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 3 of 13

     

     

              1.    NAMES OF REPORTING PERSONS.    

     

                          Charles B. Johnson

     

              2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

                          (a)

                          (b) X

     

              3.    SEC USE ONLY

     

              4.    CITIZENSHIP OR PLACE OF ORGANIZATION

     

                          USA

     

              NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

     

                          5.    SOLE VOTING POWER

     

                                      (See Item 4)

     

                          6.    SHARED VOTING POWER

     

                                      (See Item 4)

     

                          7.    SOLE DISPOSITIVE POWER

     

                                      (See Item 4)

     

                          8.    SHARED DISPOSITIVE POWER

     

                                      (See Item 4)

     

              9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

                          1,598,695

     

              10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

                          CERTAIN SHARES [ ]

     

              11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

                          4.9%

     

              12.   TYPE OF REPORTING PERSON

     

                          HC, IN (See Item 4)

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 4 of 13

     

     

              1.    NAMES OF REPORTING PERSONS.    

     

                          Rupert H. Johnson, Jr.

     

              2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

                          (a)

                          (b) X

     

              3.    SEC USE ONLY

     

              4.    CITIZENSHIP OR PLACE OF ORGANIZATION

     

                          USA

     

              NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

     

                          5.    SOLE VOTING POWER

     

                                      (See Item 4)

     

                          6.    SHARED VOTING POWER

     

                                      (See Item 4)

     

                          7.    SOLE DISPOSITIVE POWER

     

                                      (See Item 4)

     

                          8.    SHARED DISPOSITIVE POWER

     

                                      (See Item 4)

              9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

                          1,598,695

     

              10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

                          CERTAIN SHARES [ ]

     

              11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

                          4.9%

     

              12.   TYPE OF REPORTING PERSON

     

                          HC, IN (See Item 4)

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 5 of 13

     

     

              Item 1.

     

              (a)   Name of Issuer

     

                          LogicBio Therapeutics, Inc.

     

              (b)   Address of Issuer's Principal Executive Offices

     

               65 Hayden Avenue, 2nd Floor

               Lexington, MA 02421

     

              Item 2.

     

              (a)   Name of Person Filing

     

                          (i):   Franklin Resources, Inc.

     

                          (ii):  Charles B. Johnson

     

                          (iii): Rupert H. Johnson, Jr.

     

     

              (b)   Address of Principal Business Office or, if none, Residence

     

                          (i), (ii), and (iii):

                          One Franklin Parkway

                          San Mateo, CA 94403‑1906

     

              (c)   Citizenship

     

                          (i): Delaware

                          (ii) and (iii): USA

     

              (d)   Title of Class of Securities

     

                          Common Stock, par value $0.0001 per share

     

              (e)   CUSIP Number

     

                          54142F102

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 6 of 13

     

     

              Item 3.   If this statement is filed pursuant to §§240.13d‑1(b) or 240.13d‑2(b) or (c),

                                  check whether the person filing is a:

     

                            (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     

                            (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

                            (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     

                            (d) [ ] Investment company registered under section 8 of the Investment Company Act

                                            of 1940 (15 U.S.C 80a‑8).

     

                            (e) [X] An investment adviser in accordance with §240.13d‑1(b)(1)(ii)(E);

     

                            (f) [ ] An employee benefit plan or endowment fund in accordance with §240.13d‑1(b)

                                            (1)(ii)(F);

     

                            (g) [X] A parent holding company or control person in accordance with §240.13d‑1(b)

                                            (1)(ii)(G);

     

                            (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit

                                            Insurance Act (12 U.S.C. 1813);

     

                            (i) [ ] A church plan that is excluded from the definition of an investment company

                                            under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.

                                            80a‑3);

                            (j) [ ] A non‑U.S. institution in accordance with §240.13d‑1(b)(ii)(J);

     

                            (k) [ ] Group, in accordance with §240.13d‑1(b)(1)(ii)(K).

     

                            If filing as a non‑U.S. institution in accordance with §240.13d‑1(b)(1)(ii)(J),

                            please specify the type of institution:

            Item 4.   Ownership

     

            The securities reported herein are beneficially owned by one or more open or closed end

            investment companies or other managed accounts that are investment management clients of

            investment managers that are direct and indirect subsidiaries (each, an “Investment

            Management Subsidiary” and, collectively, the “Investment Management Subsidiaries”) of

            Franklin Resources Inc. (“FRI”), including the Investment Management Subsidiaries listed

            in this Item 4.  When an investment management contract (including a sub advisory

            agreement) delegates to an Investment Management Subsidiary investment discretion or

            voting power over the securities held in the investment advisory accounts that are

            subject to that agreement, FRI treats the Investment Management Subsidiary as having sole

            investment discretion or voting authority, as the case may be, unless the agreement

            specifies otherwise. Accordingly, each Investment Management Subsidiary reports on

            Schedule 13G that it has sole investment discretion and voting authority over the

            securities covered by any such investment management agreement, unless otherwise noted in

            this Item 4.  As a result, for purposes of Rule 13d‑3 under the Act, the Investment

            Management Subsidiaries listed in this Item 4 may be deemed to be the beneficial owners

            of the securities reported in this Schedule 13G.

     

            Beneficial ownership by Investment Management Subsidiaries and other FRI affiliates is

            being reported in conformity with the guidelines articulated by the SEC staff in Release

            No. 34‑39538 (January 12, 1998) (the “1998 Release”) relating to organizations, such as

            FRI, where related entities exercise voting and investment powers over the securities

            being reported independently from each other. The voting and investment powers held by

            each of FRI’s affiliates whose ownership of securities is disaggregated from that of FRI

            in accordance with the 1998 Release (“FRI Disaggregated Affiliates”) are exercised

            independently from FRI and from all other Investment Management Subsidiaries (FRI, its

            affiliates and the Investment Management Subsidiaries other than FRI Disaggregated

            Affiliates are collectively, “FRI Aggregated Affiliates”). Furthermore, internal policies

            and procedures of, on the one hand, FRI Disaggregated Affiliates, and, on the other hand,

            FRI establish informational barriers that prevent the flow among, on the one hand, FRI

        disaggregated Affiliates (including preventing the flow between such entities), and, on

     
     
     

     

              CUSIP NO. 54142F102                    13G                               Page 7 of 13

     

     

              the other hand, the FRI Aggregated Affiliates of information that relates to the voting

              and investment powers over the securities owned by their respective investment management

              clients. Consequently, FRI Disaggregated Affiliates report the securities over which they

              hold investment and voting power separately from the FRI Aggregated Affiliates for

              purposes of Section 13 of the Act.

     

              Charles B. Johnson and Rupert H. Johnson, Jr. (the “Principal Shareholders”) each own in

              excess of 10% of the outstanding common stock of FRI and are the principal stockholders

              of FRI.  FRI and the Principal Shareholders may be deemed to be, for purposes of Rule

              13d‑3 under the Act, the beneficial owners of securities held by persons and entities for

              whom or for which FRI subsidiaries provide investment management services.  The number of

              shares that may be deemed to be beneficially owned and the percentage of the class of

              which such shares are a part are reported in Items 9 and 11 of the cover pages for FRI

              and each of the Principal Shareholders.  FRI, the Principal Shareholders and each of the

              Investment Management Subsidiaries disclaim any pecuniary interest in any of such

              securities.  In addition, the filing of this Schedule 13G on behalf of the Principal

              Shareholders, FRI and the FRI Aggregated Affiliates, as applicable, should not be

              construed as an admission that any of them is, and each of them disclaims that it is, the

              beneficial owner, as defined in Rule 13d‑3, of any of the securities reported in this

              Schedule 13G.

     

              FRI, the Principal Shareholders, and each of the Investment Management Subsidiaries

              believe that they are not a “group” within the meaning of Rule 13d‑5 under the Act and

              that they are not otherwise required to attribute to each other the beneficial ownership

              of the securities held by any of them or by any persons or entities for whom or for which

              the Investment Management Subsidiaries provide investment management services.

     

     

                          (a)    Amount beneficially owned:

     

                                       1,598,695

     

                          (b)    Percent of class:

     

                                        4.9%

     

                          (c)    Number of shares as to which the person has:

     

                                  (i)   Sole power to vote or to direct the vote

     

                                                Franklin Resources, Inc.:                                        0

     

                                                Charles B. Johnson:                                              0

     

                                                Rupert H. Johnson, Jr.:                                          0

     

                                                Franklin Advisers, Inc.:                                 1,598,695

     

     

                                (ii)   Shared power to vote or to direct the vote

     

                                               0

     

                              (iii)   Sole power to dispose or to direct the disposition of

     

                                              Franklin Resources, Inc.:                                         0

     

                                              Charles B. Johnson:                                               0

     

                                              Rupert H. Johnson, Jr.:                                           0

     

                                              Franklin Advisers, Inc.:                                  1,598,695

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 8 of 13

     

                                (iv)   Shared power to dispose or to direct the disposition of

     

                                               0

     

              Item 5.  Ownership of Five Percent or Less of a Class

     

                                If this statement is being filed to report the fact that as of the date hereof

                                the reporting person has ceased to be the beneficial owner of more than five

                                percent of the class of securities, check the following [X]. 

     

              Item 6.  Ownership of More than Five Percent on Behalf of Another Person

     

                                The clients of the Investment Management Subsidiaries, including investment

                                companies registered under the Investment Company Act of 1940 and other

                                managed accounts, have the right to receive or power to direct the receipt of

                                dividends from, and the proceeds from the sale of, the securities reported

                                herein.

     

              Item 7.  Identification and Classification of the Subsidiary Which Acquired the

                                Security Being Reported on By the Parent Holding Company

     

                                See Attached Exhibit C

     

              Item 8.  Identification and Classification of Members of the Group

     

                                Not Applicable

              Item 9.  Notice of Dissolution of Group

     

                                Not Applicable

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 9 of 13

     

     

              Item 10. Certification

     

              By signing below I certify that, to the best of my knowledge and belief, the

              securities referred to above were acquired and are held in the ordinary course of

              business and were not acquired and are not held for the purpose of or with the

              effect of changing or influencing the control of the issuer of the securities and

              were not acquired and are not held in connection with or as a participant in any

              transaction having that purpose or effect, other than activities solely in

              connection with a nomination under § 240.14a‑11.

     

              Exhibits:

              Exhibit A ‑ Joint Filing Agreement

              Exhibit B ‑ Limited Powers of Attorney for Section 13 Reporting Obligations

              Exhibit C ‑ Item 7 Identification and Classification of Subsidiaries

     

                                                                                      SIGNATURE

     

              After reasonable inquiry and to the best of my knowledge and belief, I certify that

              the information set forth in this statement is true, complete and correct.

     

              Dated:   January 24, 2022

     

              Franklin Resources, Inc.

     

              Charles B. Johnson

     

              Rupert H. Johnson, Jr.

     

              By:    /s/LORI A. WEBER

                            ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑

     

                            Lori A. Weber

                            Assistant Secretary of Franklin Resources, Inc.

     

                            Attorney‑in‑Fact for Charles B. Johnson pursuant to Power of Attorney

                            attached to this Schedule 13G

     

                            Attorney‑in‑Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney

                            attached to this Schedule 13G

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 10 of 13

     

              EXHIBIT A

     

              JOINT FILING AGREEMENT

     

              In accordance with Rule 13d‑1(k) under the Securities Exchange Act of 1934, as amended,

              the undersigned hereby agree to the joint filing with each other of the attached

              statement on Schedule 13G and to all amendments to such statement and that such

              statement and all amendments to such statement are made on behalf of each of them.

     

              IN WITNESS WHEREOF, the undersigned have executed this agreement on  January 24, 2022.

     

              Franklin Resources, Inc.

     

              Charles B. Johnson

     

              Rupert H. Johnson, Jr.

     

              By:     /s/LORI A. WEBER

                              ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑

     

                              Lori A. Weber

                              Assistant Secretary of Franklin Resources, Inc.

     

                              Attorney‑in‑Fact for Charles B. Johnson pursuant to Power of Attorney

                              attached to this Schedule 13G

     

                              Attorney‑in‑Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney

                              attached to this Schedule 13G

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 11 of 13

     

     

                                                                                            EXHIBIT B

                                                                                 LIMITED POWER OF ATTORNEY

                                                          FOR SECTION 13 AND 16 REPORTING OBLIGATIONS

          Know all by these presents, that the undersigned hereby makes, constitutes and appoints

        each of Alison E. Baur, Steven J. Gray, Beth McAuley O’Malley, Thomas C. Merchant, Kimberly

        H. Novotny, Virginia E. Rosas, Navid J. Tofigh and Lori A. Weber each acting individually, as

        the undersigned’s true and lawful attorney‑in‑fact, with full power and authority as

        hereinafter described on behalf of and in the name, place and stead of the undersigned to:

                  1. prepare, execute, acknowledge, deliver and file Forms ID, Schedules 13D and 13G, and

        Forms 3, 4 and 5 (including any amendments thereto and any related documentation) with the

        United States Securities and Exchange Commission and any national securities exchanges

        relating to Franklin Resources, Inc. (“FRI”) and/or any registered closed‑end company to

        which an affiliate of FRI is an investment adviser (each, a “Reporting Entity”), as

        considered necessary or advisable under Regulation S‑T and Sections 13(d) and 16(a) of the

        Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as

        amended from time to time (the “Exchange Act”); and

                  2. seek or obtain, as the undersigned’s representative and on the undersigned’s behalf,

        information on transactions in the securities of any Reporting Entity from any person,

        including brokers, employee benefit plan administrators and trustees, and the undersigned

        hereby authorizes any such person to release any such information to the undersigned and

        approves and ratifies any such release of information; and

                  3. perform any and all other acts which in the discretion of such attorney‑in‑fact are

        necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

                  The undersigned acknowledges that:

                  1. this Limited Power of Attorney authorizes, but does not require, each such

        attorney‑in‑fact to act in their discretion on information provided to such attorney‑in‑fact

        without independent verification of such information;

                  2. any documents prepared and/or executed by any such attorney‑in‑fact on behalf of the

        undersigned pursuant to this Limited Power of Attorney will be in such form and will contain

        such information and disclosure as such attorney‑in‑fact, in his or her discretion, deems

        necessary or desirable;

                  3. none of FRI, any Reporting Entity nor any of such attorneys‑in‑fact assumes (i) any

        liability for the undersigned’s responsibility to comply with the requirements of the

        Exchange Act, (ii) any liability of the undersigned for any failure to comply with such

        requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement

        under Section 16(b) of the Exchange Act; and

                  4. this Limited Power of Attorney does not relieve the undersigned from responsibility

        for compliance with the undersigned’s obligations under the Exchange Act, including without

        limitation, the reporting requirements under Section 16 of the Exchange Act.

                  The undersigned hereby gives and grants each of the foregoing attorneys‑in‑fact full

        power and authority to do and perform all and every act and thing whatsoever requisite,

        necessary or appropriate to be done in and about the foregoing matters as fully to all

        intents and purposes as the undersigned might or could do if present, hereby ratifying all

        that each such attorney‑in‑fact of, for and on behalf of the undersigned, shall lawfully do

        or cause to be done by virtue of this Limited Power of Attorney, and indemnifies each of the

        foregoing attorneys‑in‑fact against any loss of any nature whatsoever arising in connection

        therewith.

                  This Limited Power of Attorney shall remain in full force and effect until revoked by

        the undersigned in a signed writing delivered to each such attorney‑in‑fact.

                  IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be

        executed as of this 16th day of August, 2021.

                                                        /s/CHARLES B. JOHNSON

                                                        Signature

                                                        Charles B. Johnson

                                                        Print Name

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 12 of 13

     

     

                                                                            LIMITED POWER OF ATTORNEY

                                                          FOR SECTION 13 AND 16 REPORTING OBLIGATIONS

          Know all by these presents, that the undersigned hereby makes, constitutes and appoints

        each of Alison E. Baur, Steven J. Gray, Beth McAuley O’Malley, Thomas C. Merchant, Kimberly

        H. Novotny, Virginia E. Rosas, Navid J. Tofigh and Lori A. Weber each acting individually, as

        the undersigned’s true and lawful attorney‑in‑fact, with full power and authority as

        hereinafter described on behalf of and in the name, place and stead of the undersigned to:

                  1. prepare, execute, acknowledge, deliver and file Forms ID, Schedules 13D and 13G, and

        Forms 3, 4 and 5 (including any amendments thereto and any related documentation) with the

        United States Securities and Exchange Commission and any national securities exchanges

        relating to Franklin Resources, Inc. (“FRI”) and/or any registered closed‑end company to

        which an affiliate of FRI is an investment adviser (each, a “Reporting Entity”), as

        considered necessary or advisable under Regulation S‑T and Sections 13(d) and 16(a) of the

        Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as

        amended from time to time (the “Exchange Act”); and

                  2. seek or obtain, as the undersigned’s representative and on the undersigned’s behalf,

        information on transactions in the securities of any Reporting Entity from any person,

        including brokers, employee benefit plan administrators and trustees, and the undersigned

        hereby authorizes any such person to release any such information to the undersigned and

        approves and ratifies any such release of information; and

                  3. perform any and all other acts which in the discretion of such attorney‑in‑fact are

        necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

                  The undersigned acknowledges that:

                  1. this Limited Power of Attorney authorizes, but does not require, each such

        attorney‑in‑fact to act in their discretion on information provided to such attorney‑in‑fact

        without independent verification of such information;

                  2. any documents prepared and/or executed by any such attorney‑in‑fact on behalf of the

        undersigned pursuant to this Limited Power of Attorney will be in such form and will contain

        such information and disclosure as such attorney‑in‑fact, in his or her discretion, deems

        necessary or desirable;

                  3. none of FRI, any Reporting Entity nor any of such attorneys‑in‑fact assumes (i) any

        liability for the undersigned’s responsibility to comply with the requirements of the

        Exchange Act, (ii) any liability of the undersigned for any failure to comply with such

        requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement

        under Section 16(b) of the Exchange Act; and

                  4. this Limited Power of Attorney does not relieve the undersigned from responsibility

        for compliance with the undersigned’s obligations under the Exchange Act, including without

        limitation, the reporting requirements under Section 16 of the Exchange Act.

                  The undersigned hereby gives and grants each of the foregoing attorneys‑in‑fact full

        power and authority to do and perform all and every act and thing whatsoever requisite,

        necessary or appropriate to be done in and about the foregoing matters as fully to all

        intents and purposes as the undersigned might or could do if present, hereby ratifying all

        that each such attorney‑in‑fact of, for and on behalf of the undersigned, shall lawfully do

        or cause to be done by virtue of this Limited Power of Attorney, and indemnifies each of the

        foregoing attorneys‑in‑fact against any loss of any nature whatsoever arising in connection

        therewith.

                  This Limited Power of Attorney shall remain in full force and effect until revoked by

        the undersigned in a signed writing delivered to each such attorney‑in‑fact.

                  IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be

        executed as of this 16th day of August, 2021.

                                                        /s/RUPERT H. JOHNSON, JR.

                                                        Signature

                                                        Rupert H. Johnson, Jr.

                                                        Print Name

     

     


     
     

     

              CUSIP NO. 54142F102                    13G                               Page 13 of 13

     

     

              EXHIBIT C

     

              Franklin Advisers, Inc.                               Item 3 Classification: 3(e)

     

     

     

    Get the next $LOGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LOGC

    DatePrice TargetRatingAnalyst
    2/3/2022Outperform → Market Perform
    William Blair
    2/2/2022$16.00 → $6.00Hold
    Chardan Capital
    12/23/2021$20.00 → $16.00Buy
    Chardan Capital
    11/17/2021$24.00 → $8.00Overweight
    Barclays
    11/16/2021$17.00 → $16.00Market Outperform
    JMP Securities
    More analyst ratings

    $LOGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ContextLogic Inc. Reports First-Quarter 2025 Financial Results

      OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025. First-Quarter 2025 Financial Highlights Net Loss: Net loss was $4 million, compared to a net loss of $59 million in the first quarter of fiscal year 2024.As of March 31, 2025, the Company had $64 million in cash and cash equivalents, $158 million in marketable securities and $1 million in prepaid expenses and other current assets primarily made up of restricted cash. The Company had total liabilities of $3 million. ContextLogic will host a financial results conference call a

      5/9/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic to Announce First Quarter 2025 Results on May 9, 2025

      OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on Friday, May 9, 2025. ContextLogic's CEO Rishi Bajaj and its Chairman Ted Goldthorpe will host a live conference call and webcast for shareholders, analysts and portfolio managers that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the Company's financial results, including a link to the live webcast and replay will be made available on the Company's investor relations website at https://ir.contextlogicinc.com. The live conference call may be accessed by registering

      5/6/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

      OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company's business. These included, first, the sale of the Wish platform and its associated operations; second, streamlining the Company's operations; and most recently, on March 11, 2025, the Company announced the initial closing of the investment by BC Partners of $75 million in convertible preferred units in a subsidiary of ContextLogic. This investment, along

      3/12/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Bajaj Rishi converted options into 55,856 shares and covered exercise/tax liability with 24,722 shares, increasing direct ownership by 156% to 51,134 units (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      5/8/25 4:10:12 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Director Heinberg Marshall converted options into 25,684 shares (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      4/21/25 8:44:49 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Director Farlekas Michael converted options into 25,684 shares (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      4/21/25 8:44:13 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    SEC Filings

    See more
    • SEC Form 10-Q filed by ContextLogic Inc.

      10-Q - ContextLogic Inc. (0001822250) (Filer)

      5/9/25 4:30:19 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ContextLogic Inc. (0001822250) (Filer)

      5/9/25 4:05:15 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13G/A filed by ContextLogic Inc.

      SCHEDULE 13G/A - ContextLogic Inc. (0001822250) (Subject)

      4/18/25 3:58:12 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • LogicBio Therapeutics downgraded by William Blair

      William Blair downgraded LogicBio Therapeutics from Outperform to Market Perform

      2/3/22 4:38:49 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chardan Capital reiterated coverage on LogicBio Therapeutics with a new price target

      Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Hold and set a new price target of $6.00 from $16.00 previously

      2/2/22 2:52:41 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chardan Capital reiterated coverage on LogicBio Therapeutics with a new price target

      Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Buy and set a new price target of $16.00 from $20.00 previously

      12/23/21 8:24:38 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ContextLogic Inc.

      SC 13G/A - ContextLogic Inc. (0001822250) (Subject)

      7/8/24 4:32:41 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13G/A filed by LogicBio Therapeutics Inc. (Amendment)

      SC 13G/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)

      2/14/23 1:47:10 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13D/A filed by LogicBio Therapeutics Inc. (Amendment)

      SC 13D/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)

      2/10/23 4:40:05 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Leadership Updates

    Live Leadership Updates

    See more
    • ContextLogic Announces Up to $150 Million Strategic Investment by BC Partners

      Strategic investment and capital commitment positions the Company to execute on its stated acquisition-led value maximization strategy; ContextLogic to have up to $300 million of investible cash Ted Goldthorpe, Head of BC Partners Credit, expected to be named Chairman of the Board OAKLAND, Calif. and NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") and BC Partners, an alternative investment manager with c.€40 billion in assets under management, today announced that a fund advised by BC Partners Advisors L.P. will purchase up to $150 million of convertible preferred units (the "Preferred Units") of ContextLogic Holdings, L

      2/25/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business Updates

      LEXINGTON, Mass., March 4, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today reported financial results for the year ended December 31, 2021, and provided business updates. "At LogicBio, we are continuing to advance our mission to safely deliver novel genetic medicines to people impacted by devastating, early onset diseases," said Frederic Chereau, president and chief executive officer of LogicBio. "We are pleased to report that the serious adverse event experienced by the fourth patient enrolled in our Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with methylmalonic acidemia has resolved." Recent Business Update

      3/4/22 4:05:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments

      LEXINGTON, Mass., May 19, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced the promotion of Daniel Gruskin, MD, as chief medical officer. Dr. Gruskin most recently served as senior vice president and head of clinical development. The Company also announced the appointment of Stephen Boyer, PhD, as vice president of regulatory and quality affairs, and Peter Pechan, PhD, as vice president of gene therapy, who will support progress in the Phase I/II SUNRISE clinical trial of LB-001, the Company's investi

      5/19/21 7:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Financials

    Live finance-specific insights

    See more
    • ContextLogic Inc. Reports First-Quarter 2025 Financial Results

      OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025. First-Quarter 2025 Financial Highlights Net Loss: Net loss was $4 million, compared to a net loss of $59 million in the first quarter of fiscal year 2024.As of March 31, 2025, the Company had $64 million in cash and cash equivalents, $158 million in marketable securities and $1 million in prepaid expenses and other current assets primarily made up of restricted cash. The Company had total liabilities of $3 million. ContextLogic will host a financial results conference call a

      5/9/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic to Announce First Quarter 2025 Results on May 9, 2025

      OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on Friday, May 9, 2025. ContextLogic's CEO Rishi Bajaj and its Chairman Ted Goldthorpe will host a live conference call and webcast for shareholders, analysts and portfolio managers that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the Company's financial results, including a link to the live webcast and replay will be made available on the Company's investor relations website at https://ir.contextlogicinc.com. The live conference call may be accessed by registering

      5/6/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

      OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company's business. These included, first, the sale of the Wish platform and its associated operations; second, streamlining the Company's operations; and most recently, on March 11, 2025, the Company announced the initial closing of the investment by BC Partners of $75 million in convertible preferred units in a subsidiary of ContextLogic. This investment, along

      3/12/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary